View More
Downloadable PDF resource from CCO on opioid use disorder treatment essentials for hepatologists and ID specialists managing HCV and/or HIV infection
Jenna Butner, MD
Released: May 7, 2020
Latest data and best practice guidance on treating HCV in addiction medicine settings published by Clinical Care Options (CCO)
Andrew Seaman, MD
Released: February 24, 2020
Expert commentary from CCO on how providers can act as advocates for increased access to HCV care for persons who use drugs and incarcerated individuals
Oluwaseun Falade-Nwulia, MBBS, MPH
Released: December 18, 2019
Watch this video from a live symposium for expert guidance on approaches to improve diagnosis and treatment of HCV, HBV, and NASH.
Paul Y. Kwo, MD
Manal F. Abdelmalek, MD, MPH
Oluwaseun Falade-Nwulia, MBBS, MPH
Physicians:
maximum of 1.5 AMA PRA Category 1 Credits™
US Physicians:
maximum of 1.5 Medical Knowledge MOC point(s)
Released: December 17, 2019
Expired: December 16, 2020
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.
CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.